Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility

Svetlana A. Ivanova, Valentina A. Toshchakova, Maxim L. Filipenko, Olga Yu Fedorenko, Evgenia G. Boyarko, Anastasia S. Boiko, Arkadiy V. Semke, Nikolay A. Bokhan, Lyubomir I. Aftanas, Anton J. M. Loonen

Research output: Contribution to journalArticle

10 Citations (Scopus)
Original languageEnglish
Pages (from-to)200-205
JournalWorld Journal of Biological Psychiatry
Volume16
Issue number3
DOIs
Publication statusPublished - Apr 2015

Keywords

  • tardive dyskinesia
  • schizophrenia
  • CYP1A2 gene
  • tobacco smoking
  • enzyme induction

Cite this

Ivanova, S. A., Toshchakova, V. A., Filipenko, M. L., Fedorenko, O. Y., Boyarko, E. G., Boiko, A. S., Semke, A. V., Bokhan, N. A., Aftanas, L. I., & Loonen, A. J. M. (2015). Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility. World Journal of Biological Psychiatry, 16(3), 200-205. https://doi.org/10.3109/15622975.2014.995222